ELISA Technologies Market

ELISAs (Enzyme-linked immunosorbent assays) are routinely used for the qualitative and quantitative assessment of cytokines, chemokines, growth factors, phosphorylated targets, immunoglobulins and other immunological markers. Detection and quantitation of protein analytes from various biological samplesserum, plasma, cell culture supernatants and cell lysatesindicate a multitude of biological and pathological events. ELISAs have proven to be valuable tools in drug development as they are commonly used for biomarker profiling of disease vs. normal states, as well as toxicity profiling.
ELISA Technologies Market aims to provide a comprehensive presentation of the global market for ELISA Technologies, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding ELISA Technologies. ELISA Technologies Market contains market size and forecasts of ELISA Technologies in global, including the following market information:
Global ELISA Technologies Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global top five companies in 2022 (%)
The global ELISA Technologies market was valued at US$ 184.2 million in 2022 and is projected to reach US$ 233.5 million by 2030, at a CAGR of 3.4% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Global Enzyme-Linked Immunosorbent Assay (ELISA) key players include R&D Systems, Thermo Fisher Scientific, Ortho Clinical Diagnostics, BD Biosciences, etc. Global top four manufacturers hold a share over 45%.
China is the largest market, with a share over 35%, followed by Europe, and USA, both have a share over 30 percent.
In terms of product, Indirect ELISA is the largest segment, with a share over 45%. And in terms of application, the largest application is Immunology, followed by Infectious Diseases, Protein Quantitation, Cancer, etc.
We surveyed the ELISA Technologies companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global ELISA Technologies Market, by Type, 2018-2023, 2024-2030 ($ millions)
Global ELISA Technologies Market Segment Percentages, by Type, 2022 (%)

• Sandwich ELISA
• Indirect ELISA
• Multiple and portable ELISA

• Academia
• Blood Banks
• Hospitals
• Pharma & Biotechnology Companies
• Laboratories
• Others

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

• Key companies ELISA Technologies revenues in global market, 2018-2023 (estimated), ($ millions)
• Key companies ELISA Technologies revenues share in global market, 2022 (%)

• American Laboratory Products Company (ALPCO)
• BD Biosciences
• BioMrieux SA
• Bio-Rad Laboratories
• EMD Millipore Corp
• Life Technologies Corporation
• Ortho-Clinical Diagnostics
• R&D Systems
• Thermo Fisher Scientific
• ZEUS Scientific